- Home
- WF vs PEN Comparison
WF vs PEN Comparison
Compare WF & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WF
- PEN
- Stock Information
- Founded
- WF 1899
- PEN 2004
- Country
- WF South Korea
- PEN United States
- Employees
- WF N/A
- PEN N/A
- Industry
- WF Commercial Banks
- PEN Medical/Dental Instruments
- Sector
- WF Finance
- PEN Health Care
- Exchange
- WF Nasdaq
- PEN Nasdaq
- Market Cap
- WF 8.5B
- PEN 7.0B
- IPO Year
- WF N/A
- PEN 2015
- Fundamental
- Price
- WF $33.97
- PEN $237.75
- Analyst Decision
- WF
- PEN Buy
- Analyst Count
- WF 0
- PEN 14
- Target Price
- WF N/A
- PEN $231.08
- AVG Volume (30 Days)
- WF 63.8K
- PEN 406.0K
- Earning Date
- WF 10-25-2024
- PEN 10-30-2024
- Dividend Yield
- WF 12.01%
- PEN N/A
- EPS Growth
- WF N/A
- PEN N/A
- EPS
- WF 2.64
- PEN 0.89
- Revenue
- WF $7,567,454,676.00
- PEN $1,163,776,000.00
- Revenue This Year
- WF N/A
- PEN $13.65
- Revenue Next Year
- WF $1.69
- PEN $14.38
- P/E Ratio
- WF $4.31
- PEN $268.60
- Revenue Growth
- WF 3.38
- PEN 16.96
- 52 Week Low
- WF $27.60
- PEN $148.00
- 52 Week High
- WF $38.05
- PEN $277.34
- Technical
- Relative Strength Index (RSI)
- WF 41.88
- PEN 67.09
- Support Level
- WF $33.84
- PEN $231.93
- Resistance Level
- WF $34.28
- PEN $243.39
- Average True Range (ATR)
- WF 0.37
- PEN 8.43
- MACD
- WF -0.05
- PEN 0.45
- Stochastic Oscillator
- WF 32.18
- PEN 84.72
About WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holdings company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. Its operating segments include Banking, Credit card, capital, Investment banking, and others.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.